|
|
Phoqus Pharmaceuticals PLC - Comparative Business Analysis Snapshot
Business Description
Phoqus Pharmaceuticals PLC Formerly known as Phoqus Group PLC. The Group's principal activity is developing and commercialising electrostatic deposition technology for the manufacture of tablets with tailored appearance and medical properties for the pharmaceutical industry. These are delivered using the four drug delivery systems, Qdis (fast dissolve), Qtrol (modified release), LeQtradose (active dose loading) and UniQ (unique tablet imaging). The Group operates in the United Kingdom, the United States of America and Europe.
Competitor Analysis
This analysis compares Phoqus Pharmaceuticals PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
